| Name | Title | Contact Details |
|---|---|---|
Joseph Miranda |
Chief Digital Officer | Profile |
Jana Monroe |
Vice President of Global Security | Profile |
Founded in 2004, BioRx is a national provider of specialty pharmacy, infusion management and industry consulting services. As a private, independently-owned company, BioRx is committed to a flexible service model that meets the needs of its customers, including consumers, healthcare providers, health plans and pharmaceutical manufacturers. The company’s streamlined management structure allows it to respond more quickly to changes in the marketplace and provide a higher level of service that is customized for each consumer. Moreover, BioRx helps to provide a more cost-effective level of healthcare – in particular by moving patients from costly facility-based infusion sites to their homes, thereby allowing us to closely monitor the administration and outcomes of complex infusion therapies. BioRx consumer services include home delivery of specialty intravenous and injectable pharmaceuticals, medical supplies, nursing support, reimbursement coordination, consumer advocacy, and highly customized care plans. The company also provides professional consulting services to business partners within the insurance and pharmaceutical manufacturing industries.
Incorporated in 2003, Nanobiotix is a leading, late clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes by bringing nanophysics to the heart of the cell. The Nanobiotix philosophy is one rooted in designing pioneer physical based approaches to bring highly effective and generalized solutions to address high unmet medical needs and challenges.
Pharmagistics, LLC is a Somerset, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Pharmaka is a Flemington, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ControlRad is a privately-held medical technology company developing innovative products that dramatically reduce the lifetime risk of radiation exposure from fluoroscopically guided interventional procedures (FGIP) for patients and healthcare professionals.